ZJYL · Jin Medical International Ltd.
AI read · Good for ZJYL
The AI's read
ZJYL ripped ~63% after-hours on fresh six-month results. The kicker: the company reports $9.1M cash plus $21M in short-term investments versus a ~$15M market cap, which changes the valuation math. That move already priced a lot of the news, shown by the 64% after-hours pop and very thin float volume. But the cash surplus is new hard data that can justify more upside if clean and accessible. We lean bullish because of the balance-sheet asymmetry and improving margins despite weaker revenue. Conviction is tempered because the rally is large, liquidity is thin, and execution or accounting risks could kill the run.